Skip to main content

CORRECTION article

Front. Chem., 04 February 2022
Sec. Chemical Biology
This article is part of the Research Topic COVID-19: Targeting Essential SARS-CoV-2 Proteins for Drug Discovery View all 14 articles

Corrigendum: Inhibition of SARS-CoV-2 by Targeting Conserved Viral RNA Structures and Sequences

  • Department of Medicinal Chemistry, University of Kansas, Lawrence, KS, United States

A Corrigendum on
Inhibition of SARS-CoV-2 by Targeting Conserved Viral RNA Structures and Sequences

by Hegde, S., Tang, Z., Zhao, J., and Wang, J. (2021). Front. Chem. 9:802766. doi:10.3389/fchem.2021.802766

In the original article, there was a mistake in Figure 4 as published. Figure 4 was a duplication of Figure 6. The corrected Figure 4 appears below.

FIGURE 4
www.frontiersin.org

FIGURE 4. The small molecules with antiviral activities targeting the SARS-CoV-2 RNA genome.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: SARS-CoV-2, antiviral, RNA-targeting, small molecule, antisense oligonucleotide, untranslated region, programmed frameshift, RIBOTAC

Citation: Hegde S, Tang Z, Zhao J and Wang J (2022) Corrigendum: Inhibition of SARS-CoV-2 by Targeting Conserved Viral RNA Structures and Sequences. Front. Chem. 10:842171. doi: 10.3389/fchem.2022.842171

Received: 23 December 2021; Accepted: 11 January 2022;
Published: 04 February 2022.

Edited and reviewed by:

Jun Wang, Rutgers, The State University of New Jersey, United States

Copyright © 2022 Hegde, Tang, Zhao and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Jingxin Wang, d2FuZy5qaW5neGluQGt1LmVkdQ==

These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.